David Komatsu, Ph.D.
 Senior Scientist/Manager, Biologics/Biomaterials Laboratory EducationPh.D. Biomedical Engineering M.S. Biomedical Engineering Stony Brook University, Stony Brook, New York B.A. Psychology University of California, Santa Barbara, California ExperiencePost-Doctorate Fellow, Integrative Biology Eli Lily and Company, Indianapolis, Indiana Orthopaedics Research Laboratory, Indiana University, Caramel, Indiana Research Assistant, Molecular & Cellular Bioengineering Lab Stony Brook University, Stony Brook, New York ExpertiseAnimal models Gel electrophoresis histology Immunohistochemistry/precipitation Gene cloning Micro computed tomography Microscopy Northern and Western blots Recombinant and fusion proteins RNA, DNA protein isolation Tissue culture PatentsMustang, a gene and nuclear protein. US Patent #7,238,799. PublicationsKomatsu DE, Bosch-Marce M, Semenza GL, Hadjiargyrou, M. Enhanced Bone Regeneration Associated with Decreased Apoptosis in Mice with Partial HIF-1alpha Deficiency. J Bone Miner Res. 2007; 22: 366-374. Komatsu DE, Hadjiargyrou M. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone. 2004; 34:680-688. Lombardo, F., Komatsu, D. and Hadjiargyrou, M. Molecular cloning and characterization of Mustang, a novel nuclear protein expressed during skeletal development and regeneration. The FASEB Journal. 2004; 18: 52-61. |